Material
Two-peptide blend
Metabolic research
CJC-1295 + Ipamorelin10 MG
A combination research format for controlled study of endocrine-signaling models.
MaterialTwo-peptide blend
SpecificationPurity 99%+
Research contextEndocrine-signaling research.
Veyvanta / profile
Compound profile
* Vial labels may use shortened names to keep the label legible. The full material and composition are stated in this profile.
Composition
CJC-1295 5 MG + Ipamorelin 5 MG.
Research context
Endocrine-signaling research.
Research interest
Why it draws attention
The blend combines complementary GHRH and ghrelin-receptor research pathways, attracting interest around coordinated growth-hormone secretory signaling.
Signals researchers are following
- 01
Growth-hormone and IGF-1 secretory dynamics
- 02
GHRH and ghrelin-receptor pathway interaction
Evidence levelComponent-level evidence
Published evidence / research profile
What the published research shows
A source-led view of the findings reported to date, the maturity of the evidence, and the limits that matter when interpreting it.
Evidence levelComponent-level evidence
Common research directions
- Growth-hormone and IGF-1 secretory dynamics
- GHRH and ghrelin-receptor pathway interaction
Reported findings
Early human studies of CJC-1295 reported sustained increases in GH and IGF-1. Healthy-volunteer PK/PD research also characterized a clear, episodic GH-release response to ipamorelin across the studied range. Direct clinical evidence for the combined blend remains limited.
How to read the evidence
Evidence is component-level and depends on exact molecular form. In particular, the duration of CJC-1295 differs by analogue and DAC status, which cannot be inferred from a shortened vial label.
Selected references
This summary describes published research on the named material or its components. It does not establish safety, efficacy, equivalence, or suitability of this Veyvanta research product for human use.
Lab math
Reconstitution & measurement calculator
Convert a declared vial amount and diluent volume into nominal concentration, liquid volume, and the equivalent position on a U-100 scale.
Research product
Research productCJC-1295 + Ipamorelin / 10 MG
Component mode calculates against one declared ingredient. Total mode calculates against the full declared blend mass.
Calculated measurement
Enter a positive diluent volume and target amount to calculate.
A calculation, not a protocol
This tool performs unit conversion only. It does not recommend an amount, frequency, route, diluent, handling method, or human use. Results assume ideal mixing and a U-100 scale of 100 units per mL; validated laboratory procedures and material-specific compatibility take priority.
Vial verification
Verify this vial
This is the evergreen product profile. Enter the code from a physical vial to display its specific record.
Verify this vial
Vial verification QR
This QR code opens the current product profile with its associated vial record.
Metabolic research
